Search for: "People v F. N. W." Results 41 - 60 of 586
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
7 Apr 2011, 1:16 pm by Bexis
Dammann & Co., 594 F.3d 238, 253 (3d Cir. 2010):[W]e have exercised restraint in accordance with the well-established principle that where two competing yet sensible interpretations of state law exist, we should opt for the interpretation that restricts liability, rather than expands it, until the Supreme Court of [that state] decides differently.Lexington National Insurance Corp. v. [read post]
1 Jan 2019, 3:12 pm
  Existing evidence suggests that the Babalawos of the different branches of the faith in the nation started to gather together  to invoke with all rigor the appropriate ceremonies that concluded on the 1st of January) with the opening of the Letter of the Year).The object of the annual letter is to provide guidance for the nation and its people. [read post]
9 Feb 2012, 5:20 am by Nicholas J. Wagoner
& Loan Ass'n., 763 F.2d 1166, 1169 (10th Cir. 1985) (citation omitted). [read post]
22 Apr 2024, 5:00 am by Bernard Bell
Trump, 928 F. 3d 226 (2d Cir. 2019), vacated as moot sub nom, Biden v. [read post]
15 Dec 2011, 11:28 am
De Alba Pagan, 33 F.3d 125, 129 (1st Cir. 1994) (citing United States v. [read post]
18 Nov 2018, 7:12 pm by Eugene Volokh
Nat'l Fed'n of the Blind of N.C., Inc., 487 U.S. 781, 796–97 (1988). [2].W. [read post]
18 Nov 2018, 7:12 pm by Eugene Volokh
Nat'l Fed'n of the Blind of N.C., Inc., 487 U.S. 781, 796–97 (1988). [2].W. [read post]
13 Jun 2011, 3:01 pm by Eugene Volokh
Reese, 627 F.3d 792, 801–02 (10th Cir.2010) (applying intermediate scrutiny to review of § 922(g)(8)); United States v. [read post]
23 Mar 2017, 10:31 am by Rebecca Tushnet
Any general claims about distinctiveness must take into account: eligibility for protection/scope of protection; reality v. policy; words v. non-words; perception by single consumers v. aggregate; consumer search costs approach v. product goodwill approach; US v. [read post]
11 Aug 2016, 5:35 pm by Rebecca Tushnet
Boundary crossing: sharing research w/community at large v. within the pharma co. [read post]